Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazol
2. Methanone, (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride, (r)-
3. Nasea
4. Ramosetron
5. Ym 060
6. Ym-060
7. Ym060
1. 132907-72-3
2. Ramosetron Hcl
3. Nasea
4. Irribow
5. Ym060
6. Ym-060
7. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzo[d]imidazol-6-yl)methanone Hydrochloride
8. Ym 060
9. Ramosetron.hcl
10. Ramosetron (hydrochloride)
11. (r)-(-)-ramosetron Hydrochloride
12. 9551lhd87e
13. Dsstox_cid_1223
14. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone;hydrochloride
15. (r)-5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazole Hydrochloride
16. Dsstox_rid_76021
17. Dsstox_gsid_21223
18. Ramosetron Hydrochloride (jan)
19. Ramosetron Hydrochloride [jan]
20. Ccris 7704
21. Cas-132907-72-3
22. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-
23. Unii-9551lhd87e
24. (r)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1h-benzimidazole Hydrochloride
25. Nasea Od
26. (-)-(r)-5-((1-methyl-1h-indol-3-yl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazole Monohydrochloride
27. (-)-(r)-5-[(1-methyl-1h-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1h-benzimidazole Monohydrochloride
28. Methanone, (1-methyl-1h-indol-3-yl)((6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl)-, Hydrochloride (1:1)
29. Methanone, (1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]-, Hydrochloride (1:1)
30. Irribow (tn)
31. Nasea (tn)
32. Ramosetron Hydrochloride,(s)
33. Methanone, (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride, (r)-
34. Schembl447023
35. Chembl3181841
36. Dtxsid3021223
37. Chebi:32088
38. Act02590
39. Amy15420
40. Hy-b0595
41. Ym060ym-060
42. Tox21_112441
43. Mfcd19441800
44. Ramosetron Hydrochloride [mi]
45. S3723
46. Akos015895434
47. Tox21_112441_1
48. Ccg-267653
49. Ks-1311
50. Ramosetron Hydrochloride [mart.]
51. Ncgc00167437-02
52. Ramosetron Hydrochloride [who-dd]
53. (1-methyl-1h-indol-3-yl)[(5r)-4,5,6,7-tetrahydro-1h-benzimidazol-5-yl]methanone Hydrochloride
54. (1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]methanone Hydrochloride
55. Methanone, (1-methyl-1h-indol-3-yl)((5r)-4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride
56. R-145
57. D02016
58. 907r723
59. A806524
60. Q27271742
61. (r)-(-)-5-[(1-methylindol-3-yl)carbonyl]-4,5,6,7-tetrahydrobenzimidazole Hydrochloride
62. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone;hydrochloride.
63. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzo[d]imidazol-5-yl)methanone Hydrochloride
Molecular Weight | 315.8 g/mol |
---|---|
Molecular Formula | C17H18ClN3O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 315.1138399 g/mol |
Monoisotopic Mass | 315.1138399 g/mol |
Topological Polar Surface Area | 50.7 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 413 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Market Place
ABOUT THIS PAGE
65
PharmaCompass offers a list of Ramosetron HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ramosetron HCl manufacturer or Ramosetron HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ramosetron HCl manufacturer or Ramosetron HCl supplier.
PharmaCompass also assists you with knowing the Ramosetron HCl API Price utilized in the formulation of products. Ramosetron HCl API Price is not always fixed or binding as the Ramosetron HCl Price is obtained through a variety of data sources. The Ramosetron HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (R)-(-)-Ramosetron Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (R)-(-)-Ramosetron Hydrochloride, including repackagers and relabelers. The FDA regulates (R)-(-)-Ramosetron Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (R)-(-)-Ramosetron Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (R)-(-)-Ramosetron Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (R)-(-)-Ramosetron Hydrochloride supplier is an individual or a company that provides (R)-(-)-Ramosetron Hydrochloride active pharmaceutical ingredient (API) or (R)-(-)-Ramosetron Hydrochloride finished formulations upon request. The (R)-(-)-Ramosetron Hydrochloride suppliers may include (R)-(-)-Ramosetron Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of (R)-(-)-Ramosetron Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a (R)-(-)-Ramosetron Hydrochloride Drug Master File in Korea ((R)-(-)-Ramosetron Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of (R)-(-)-Ramosetron Hydrochloride. The MFDS reviews the (R)-(-)-Ramosetron Hydrochloride KDMF as part of the drug registration process and uses the information provided in the (R)-(-)-Ramosetron Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a (R)-(-)-Ramosetron Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their (R)-(-)-Ramosetron Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of (R)-(-)-Ramosetron Hydrochloride suppliers with KDMF on PharmaCompass.
(R)-(-)-Ramosetron Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (R)-(-)-Ramosetron Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (R)-(-)-Ramosetron Hydrochloride GMP manufacturer or (R)-(-)-Ramosetron Hydrochloride GMP API supplier for your needs.
A (R)-(-)-Ramosetron Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to (R)-(-)-Ramosetron Hydrochloride's compliance with (R)-(-)-Ramosetron Hydrochloride specifications and serves as a tool for batch-level quality control.
(R)-(-)-Ramosetron Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each (R)-(-)-Ramosetron Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(R)-(-)-Ramosetron Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia ((R)-(-)-Ramosetron Hydrochloride EP), (R)-(-)-Ramosetron Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((R)-(-)-Ramosetron Hydrochloride USP).